Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MA.NI.LA. trial of metronomic oral vinorelbine maintenance in advanced non-small cell lung cancer
2012-001103-21Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in non-small cell lung cancer (NSCLC) comparing Metronomic oral vinorelbine maintenance with Best supportive care control (2 arms). Primary endpoint: Progression-free survival. Started Jun 2012; status: completed.
02
Drugs
vinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2012-001103-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001103-21.